Understanding the Market | AUSTAR surged over 54% in the late trading session, AUSTAR Group is a provider of technology-based pharmaceutical engineering solutions
AUSTAR Life Science Technology's late trading gains expanded by over 54%. As of the time of writing, it rose by 48.04%, priced at HKD 1.51, with a transaction volume of HKD 8.4778 million. Public information shows that Hong Kong AUSTAR Group is a technology-based pharmaceutical engineering solution provider. As one of the main members of the group, AUSTAR Life Science's products and services division covers nine sectors: sterile drug production contamination control consumables, equipment and services, environmental monitoring and testing systems, validation and single equipment, biological upstream process systems, disposable process systems, laboratory information technology, and life science consulting. AUSTAR Life Science Technology's interim results show that the profit attributable to shareholders was HKD 24.999 million, an increase of 325.37% year-on-year
According to the Zhitong Finance APP, AUSTAR (06118) saw its late trading increase by over 54%, and as of the time of publication, it rose by 48.04% to HKD 1.51, with a trading volume of HKD 8.4778 million.
Public information shows that Hong Kong AUSTAR Group is a technology-based pharmaceutical engineering solution provider. As one of the main members of the group, the AUSTAR Life Sciences Products and Services Division covers nine sectors: sterile drug production contamination control consumables, equipment and services, environmental monitoring and testing systems, validation and single equipment, biological upstream process systems, disposable process systems, laboratory information technology, and life sciences consulting. AUSTAR Life Science's interim results show that the profit attributable to shareholders was HKD 24.999 million, an increase of 325.37% year-on-year
